 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
EDITORIAL Free access
International Angiology 2018 December;37(6):427-30
DOI: 10.23736/S0392-9590.18.04069-5
Copyright © 2018 EDIZIONI MINERVA MEDICA
language: English
Rivaroxaban for post-discharge thromboprophylaxis: the MARINER trial
Eduardo RAMACCIOTTI ✉, Jawed FAREED
Hemostasis and Thrombosis Research Laboratories, Loyola University Medical Center, Maywood, IL, USA